Phan Dillon
Chief Tech/Sci/R&D Officer at IBIO, INC.
Phan Dillon active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IBIO, INC. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Phan Dillon
Former positions of Phan Dillon
| Companies | Position | Start | End |
|---|---|---|---|
| PFENEX INC. | Corporate Officer/Principal | - | - |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - | - |
Training of Phan Dillon
| The University of Texas at Austin | Doctorate Degree |
| University of California, Davis | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| IBIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Phan Dillon
- Experience
